Saltar al contenido
Merck
  • Synergistic effect of quercetin and quinic acid by alleviating structural degeneration in the liver, kidney and pancreas tissues of STZ-induced diabetic rats: a mechanistic study.

Synergistic effect of quercetin and quinic acid by alleviating structural degeneration in the liver, kidney and pancreas tissues of STZ-induced diabetic rats: a mechanistic study.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (2014-06-24)
Aditya Arya, Mazen M Jamil Al-Obaidi, Nayiar Shahid, Mohamed Ibrahim Bin Noordin, Chung Yeng Looi, Won Fen Wong, Si Lay Khaing, Mohd Rais Mustafa
RESUMEN

The aim of this study was to investigate the synergistic effects of quercetin (QE) and quinic acid (QA) on a STZ-induced diabetic rat model to determine their potential role in alleviating diabetes and its associated complications. In our study design, diabetic rats were treated with single and combined doses of QE and QA for 45days to analyse their effects on liver, kidney and pancreas tissues. The study result showed that QE and QA treated groups down-regulated hyperglycaemia and oxidative stress by up-regulating insulin and C-peptide levels. Moreover, histological observations of the liver, kidney and pancreas of diabetic rats treated with single and combined doses of QE and QA showed a significant improvement in the structural degeneration. Interestingly, the combination dose of QE and QA (50 mg/kg) exhibited maximum inhibition of the pro-apoptotic protein Bax expression and demonstrate enhancement of the anti-apoptotic protein Bcl-2 expression in the kidney tissues, suggesting a protective role in the kidneys of diabetic rats. Taken together, these results indicates the synergistic effects of QE and QA in ameliorating hyperglycaemia, hyperlipidemia and insulin resistance in diabetic rats and therefore, open a new window of research on the combinatorial therapy of flavonoids.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Estroptozocina, ≥75% α-anomer basis, ≥98% (HPLC), powder
Sigma-Aldrich
Quercetin, ≥95% (HPLC), solid
Sigma-Aldrich
D-(−)-Quinic acid, 98%
USP
Quercetin dihydrate, United States Pharmacopeia (USP) Reference Standard
Supelco
Quercetin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Quinic Acid, Pharmaceutical Secondary Standard; Certified Reference Material